Registration number:
Hesgyn Limited
for the Year Ended 31 July 2024
Hesgyn Limited
(Registration number: 09109204)
Balance Sheet as at 31 July 2024
Note |
2024 |
2023 |
|
Fixed Assets |
|||
Tangible Assets |
|
- |
|
Investment property |
|
|
|
|
|
||
Current assets |
|||
Debtors |
|
|
|
Cash at bank and in hand |
|
|
|
|
|
||
Creditors: Amounts falling due within one year |
( |
( |
|
Net current liabilities |
( |
( |
|
Total assets less current liabilities |
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
Net assets |
|
|
|
Capital and Reserves |
|||
Called up share capital |
|
|
|
Retained Earnings |
|
|
|
Shareholders' funds |
|
|
For the financial year ending 31 July 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
• |
|
• |
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the Directors have not delivered to the registrar a copy of the Profit and Loss Account.
Hesgyn Limited
(Registration number: 09109204)
Balance Sheet as at 31 July 2024
Approved and authorised by the
......................................... |
Hesgyn Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
General information |
The Company is a private company limited by share capital, incorporated in United Kingdom.
The address of its registered office is:
UK
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
Tangible Assets
Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
Asset class |
Depreciation method and rate |
Office Equipment |
33% Straight Line |
Motor Vehicles |
25% Reducing balance |
Investment property
Hesgyn Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
Borrowings
Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.
Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.
Share capital
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
Staff numbers |
The average number of persons employed by the Company (including Directors) during the year, was
Tangible Assets |
Office equipment |
Motor vehicles |
Total |
|
Cost or valuation |
|||
At 1 August 2023 |
|
- |
|
Additions |
|
|
|
At 31 July 2024 |
|
|
|
Depreciation |
|||
At 1 August 2023 |
|
- |
|
At 31 July 2024 |
|
- |
|
Carrying amount |
|||
At 31 July 2024 |
|
|
|
Hesgyn Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
Investment properties |
2024 |
|
At 1 August |
|
Disposals |
( |
At 31 July |
|
In the opinion of the directors there had been no material change in the fair value of investment property held at 31 July 2024.
Debtors |
Current |
2024 |
2023 |
Trade Debtors |
|
|
Prepayments |
|
- |
Other debtors |
|
- |
|
|
Creditors |
Creditors: amounts falling due within one year
Note |
2024 |
2023 |
|
Due within one year |
|||
Loans and borrowings |
|
- |
|
Accruals and deferred income |
|
|
|
Other creditors |
|
|
|
|
|
Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £11,069 (2023 - £nil).
2024 |
2023 |
|
Current loans and borrowings |
||
HP and finance lease liabilities |
|
- |
Hesgyn Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 July 2024
Creditors: amounts falling due after more than one year
Note |
2024 |
2023 |
|
Due after one year |
|||
Loans and borrowings |
|
|
Creditors include bank loans and overdrafts and net obligations under finance lease and hire purchase contracts which are secured of £36,311 (2023 - £113,113).
Dividends |
Interim dividends paid
2024 |
2023 |
|||
Interim dividend of £ |
|
|
||